Not exact matches
The
study is similar to a clinical
trial the Mahidol group recently completed along the
Thai / Myanmar border.
MHRP, which led the RV144
trial with the
Thai Ministry of Public Health, initiated follow - on clinical
studies to conduct intensive immunogenicity research.
Many scientists believe that the
Thai HIV vaccine
trial, which had recruited over 2,500 of its projected 16,000 participants by June 2004, has no chance of success.4 Yet the investigators overseeing the
study (who include American scientists), the local
Thai institutional review boards, and the
Thai Ministry of Health have all remained silent — at least on the record.
It played a critical role landmark RV144 «
Thai Study,» a 16,000 person study which was the only HIV vaccine trial to date to demonstrate modest (31 %) efficacy of a potential HIV vaccine, and the follow - on studies on the RV144 correlates of
Study,» a 16,000 person
study which was the only HIV vaccine trial to date to demonstrate modest (31 %) efficacy of a potential HIV vaccine, and the follow - on studies on the RV144 correlates of
study which was the only HIV vaccine
trial to date to demonstrate modest (31 %) efficacy of a potential HIV vaccine, and the follow - on
studies on the RV144 correlates of risk.